Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

IGF2BP1 harbors prognostic significance by gene gain and diverse expression in neuroblastoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 10 Apr 2015

Bell Jessica L, Turlapati Raseswari, Liu Tao, Schulte Johannes H, Hüttelmaier Stefan

Abstract excerpt

PURPOSE: Chromosomal 17q21-ter gain in neuroblastoma is both a common and prognostically significant event. The insulin-like growth factor-2 mRNA-binding protein 1 (IGF2BP1) gene is located near the proximal edge of this region. Here, its prognostic value is evaluated in neuroblastoma. METHODS: T...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease-Free Survival
Share to Gene Amplification
Share to Gene Dosage

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kaplan-Meier Estimate

Share to N-Myc Proto-Oncogene Protein

Share to Neuroblastoma

Share to Oncogene Proteins

Share to Proportional Hazards Models

Source

Identifiers

PMID: 25753434
DOI: 10.1200/JCO.2014.55.9880

Genes

MYCN

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25753434-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

IGF2BP1 harbors prognostic significance by gene gain and diverse expression in neuroblastoma.PMID 25753434Read ↗

IGF2BP1 induces high-risk neuroblastoma and forms a druggable feedforward loop with MYCN promoting 17q oncogene expressionSemantic proximity Read ↗

IGF2BP1 induces neuroblastoma via a druggable feedforward loop with MYCN promoting 17q oncogene expressionSemantic proximity Read ↗

Identification of candidate genes involved in neuroblastoma progression by combining genomic and expression microarrays with survival data.Semantic proximity Read ↗

Genomic coamplification of CDK4/MDM2/FRS2 is associated with very poor prognosis and atypical clinical features in neuroblastoma patientsSemantic proximity Read ↗

IGF2BP1 enhances an aggressive tumor cell phenotype by impairing miRNA-directed downregulation of oncogenic factors.Semantic proximity Read ↗

Identification of a novel recurrent 1q42.2‐1qter deletion in high risk <i>MYCN</i> single copy 11q deleted neuroblastomasSemantic proximity Read ↗

<i>EIF4EBP1</i> is transcriptionally upregulated by MYCN and associates with poor prognosis in neuroblastomaSemantic proximity Read ↗

Characterization of amplicons in neuroblastoma: high-resolution mapping using DNA microarrays, relationship with outcome, and identification of overexpressed genes.Semantic proximity Read ↗

Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroupSemantic proximity Read ↗

Expression profiling and characterization of 4200 genes cloned from primary neuroblastomas: identification of 305 genes differentially expressed between favorable and unfavorable subsetsSemantic proximity Read ↗

Prognostic significance of MYCN related genes in pediatric neuroblastoma: a study based on TARGET and GEO datasetsSemantic proximity Read ↗

Insulin-Like Growth Factor 2 mRNA-Binding Protein 1 (IGF2BP1) Is a Prognostic Biomarker and Associated with Chemotherapy Responsiveness in Colorectal CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.